<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="en" article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molecules</journal-id>
      <journal-title>Molecules</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molecules</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molecules</abbrev-journal-title>
      <issn pub-type="epub">1420-3049</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/10010312</article-id>
      <article-id pub-id-type="publisher-id">molecules-10-00312</article-id>
      <article-categories>
        <subj-group>
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Asymmetric Synthesis of Double Bond Isomers of the Structure Proposed for Pyrinodemin A and Indication of Its Structural Revision</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ishiyama</surname>
            <given-names>Haruaki</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tsuda</surname>
            <given-names>Masashi</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Endo</surname>
            <given-names>Tadashi</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kobayashi</surname>
            <given-names>Jun&#x2019;ichi</given-names>
          </name>
          <xref rid="c1-molecules-10-00312" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
	  <aff id="af1-molecules-10-00312">Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan. Tel: (+81) 11-706-4985, Fax: (+81) 11-706-4989</aff>
      <author-notes>
        <corresp id="c1-molecules-10-00312"><label>*</label>Author to whom correspondence should be addressed; E-Mail: <email>jkobay@pharm.hokudai.ac.jp</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>01</month>
        <year>2005</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>01</month>
        <year>2005</year>
      </pub-date>
      <volume>10</volume>
      <issue>1</issue>
      <fpage>312</fpage>
      <lpage>316</lpage>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>12</month>
          <year>2004</year>
        </date>
        <date date-type="rev-recd">
          <day>24</day>
          <month>01</month>
          <year>2005</year>
        </date>
        <date date-type="accepted">
          <day>24</day>
          <month>01</month>
          <year>2005</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2005 by MDPI (http://www.mdpi.org).</copyright-statement>
        <copyright-year>2005</copyright-year>
        <license license-type="open-access">
          <p>Reproduction is permitted for noncommercial purposes.</p>
        </license>
      </permissions>
      <abstract>
        <p>Asymmetric synthesis of double bond isomers (+)-<bold>2</bold> (&#x394;<sup>15&#x2019;,16&#x2019;</sup>) and (+)-<bold>3</bold> (&#x394;<sup>14&#x2019;,15&#x2019;</sup>) of the structure (<bold>1</bold>) (&#x394;<sup>16&#x2019;,17&#x2019;</sup>) proposed for pyrinodemin A, a cytotoxic <italic>bis</italic>-pyridine alkaloid with a unique <italic>cis</italic>-cyclopent[<italic>c</italic>]isoxazolidine moiety from a marine sponge, has been accomplished. Pyrinodemin A was indicated to be a 1:1 racemic mixture of <bold>2</bold> from comparison of C<sub>18</sub> and chiral HPLC analysis for pyrinodemin A and the synthetic compounds as well as ESIMS data of oxidative degradation products of pyrinodemin A.</p>
      </abstract>
      <kwd-group>
        <kwd>Pyrinodemin A</kwd>
        <kwd><italic>Amphimedon</italic> sp.</kwd>
        <kwd>asymmetric synthesis</kwd>
        <kwd>structural revision</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Pyrinodemin A, a cytotoxic <italic>bis</italic>-pyridine alkaloid with a unique <italic>cis</italic>-cyclopent[<italic>c</italic>]isoxazolidine moiety, has been isolated from a marine sponge <italic>Amphimedon</italic> sp., and its relative stereostructure was proposed as <bold>1</bold> (&#x394;<sup>16&#x2019;,17&#x2019;</sup>) on the basis of spectral data [<xref ref-type="bibr" rid="B1-molecules-10-00312">1</xref>]. The unique structure of pyrinodemin A has prompted synthetic chemists to its total synthesis of <bold>1</bold> as well as syntheses of the double bond isomers <bold>2</bold> (&#x394;<sup>15&#x2019;,16&#x2019;</sup>) and <bold>3</bold> (&#x394;<sup>14&#x2019;,15&#x2019;</sup>) [<xref ref-type="bibr" rid="B2-molecules-10-00312">2</xref>,<xref ref-type="bibr" rid="B3-molecules-10-00312">3</xref>,<xref ref-type="bibr" rid="B4-molecules-10-00312">4</xref>] followed by different proposals of the structural revision of pyrinodemin A to be <bold>2</bold> [<xref ref-type="bibr" rid="B2-molecules-10-00312">2</xref>] or <bold>3</bold> [<xref ref-type="bibr" rid="B3-molecules-10-00312">3</xref>,<xref ref-type="bibr" rid="B4-molecules-10-00312">4</xref>].</p>
    <p>In order to examine the correct structure of pyrinodemin A, we have synthesized (+)-<bold>2</bold> and (+)-<bold>3</bold>, the double bond isomers of <bold>1</bold>, as an optically active form, and compared HPLC profiles of the synthetic compounds and pyrinodemin A. In addition, oxidative degradation experiments were performed for a remaining small amount of pyrinodemin A to determine the position of a double bond. In this paper, we describe asymmetric synthesis of (+)-<bold>2</bold> and (+)-<bold>3</bold>, and indication of the structure of pyrinodemin A to be (&#xB1;)-<bold>2</bold>.</p>
	<p><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-10-00312-i001.tif"/></p>
	 <p>The &#x394;<sup>15&#x2019;,16&#x2019;</sup> double bond isomer (+)-<bold>2</bold> was synthesized as follows (<xref ref-type="scheme" rid="molecules-10-00312-f002">Scheme 1</xref>). The synthesis of hydroxylamine <bold>6a</bold> commenced with known pivaloate <bold>5a</bold> [<xref ref-type="bibr" rid="B5-molecules-10-00312">5</xref>]. Oxidation of alcohol <bold>5a</bold> with 2-iodobenzoic acid (IBX) [<xref ref-type="bibr" rid="B6-molecules-10-00312">6</xref>] in DMSO and THF afforded its aldehyde. Treatment of the aldehyde with NH<sub>2</sub>OH&#xB7;HCl and NaOAc in MeOH provided oxime which was reduced with NaBH<sub>3</sub>CN in MeOH to afford hydroxylamine <bold>6a</bold> [<xref ref-type="bibr" rid="B7-molecules-10-00312">7</xref>,<xref ref-type="bibr" rid="B8-molecules-10-00312">8</xref>]. Condensation of <bold>6a</bold> and optically active aldehyde <bold>7</bold> [<xref ref-type="bibr" rid="B8-molecules-10-00312">8</xref>] in CHCl<sub>3</sub> containing Na<sub>2</sub>SO<sub>4</sub> at r.t. gave the nitrone <bold>8a</bold>, which was followed by heating to afford <italic>cis</italic>-cyclopent[<italic>c</italic>]isoxazolidine [<xref ref-type="bibr" rid="B9-molecules-10-00312">9</xref>] <bold>9a</bold> in 58% yield.</p>
    <fig id="molecules-10-00312-f002" position="float">
      <object-id pub-id-type="pii">molecules-10-00312-scheme1_Scheme 1</object-id>
      <label>Scheme 1</label>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-10-00312-g002.tif"/>
	  </fig>
	  <p><italic>Reagents and conditions</italic>: (a) IBX, DMSO, THF (69%); (b) H<sub>2</sub>NOH&#xB7;HCl, AcONa, MeOH (96%); (c) NaBH<sub>3</sub>CN, MeOH, pH 3, 0 &#xB0;C; (d) Na<sub>2</sub>SO<sub>4</sub>, <bold>6</bold>, CHCl<sub>3</sub>, r.t.~reflux (58% for 2 steps); (e) 3N HCl, dioxane (80%); (f) NaIO<sub>4</sub>, MeCN, H<sub>2</sub>O, 0 &#xB0;C; (g) Br-[Ph<sub>3</sub><sup>+</sup>(CH<sub>2</sub>)<sub>5</sub>CH<sub>2</sub>OH], <italic>n</italic>-BuLi, THF, 0 &#xB0;C (51% for 2 steps); (h) TIPSCl, imidazole, CH<sub>2</sub>Cl<sub>2</sub> (75%); (i) H<sub>2</sub>, Pd-C, MeOH (93%); (j) DIBAL, CH<sub>2</sub>Cl<sub>2</sub>, -78 &#xB0;C (75%); (k) IBX, DMSO (80%); (l) Br-[Ph<sub>3</sub>P<sup>+</sup>(CH<sub>2</sub>)<sub>7</sub>CH<sub>2</sub>OH], <italic>n</italic>-BuLi, THF, 0 &#xB0;C (81%); (m) 46% HF, MeCN (55%); (n) CBr<sub>4</sub>, Ph<sub>3</sub>P (80%); (o) 3-methylpyridine, LDA, DMPU, -40 &#xB0;C (64%)</p>
    <p>Treatment of <bold>9a</bold> with 3N HCl in dioxane gave diol, which was converted into its aldehyde by treatment with NaIO<sub>4</sub> and then into alcohol <bold>10a</bold> by Wittig reaction [<xref ref-type="bibr" rid="B10-molecules-10-00312">10</xref>]. Protection of alcohol <bold>10a</bold> as its TIPS ether followed by reduction with Pd-C gave its saturated TIPS ether, which was converted into alcohol <bold>11a</bold> with DIBAL. IBX oxidation of <bold>11a</bold> followed by Wittig reaction [<xref ref-type="bibr" rid="B10-molecules-10-00312">10</xref>] afforded its unsaturated alcohol, which was subjected to deprotection with HF to give diol <bold>12a</bold> in 55 %. Treatment of diol <bold>12a</bold> with CBr<sub>4</sub> and PPh<sub>3</sub> provided its dibromide, which was coupled with 3-methypyridine using LDA and DMPU [<xref ref-type="bibr" rid="B11-molecules-10-00312">11</xref>] in THF to furnish optically active compound (+)-<bold>2</bold>. This is the first synthesis of optical active form of <bold>2</bold>, although its racemic form ((&#xB1;)-<bold>2</bold>) has been synthesized [<xref ref-type="bibr" rid="B2-molecules-10-00312">2</xref>,<xref ref-type="bibr" rid="B3-molecules-10-00312">3</xref>,<xref ref-type="bibr" rid="B4-molecules-10-00312">4</xref>]. The &#x394;<sup>14&#x2019;,15&#x2019;</sup> double bond isomer (+)-<bold>3</bold> was prepared from pivaloate <bold>5b</bold> by almost same procedure as described for synthesis of (+)-<bold>2</bold> (<xref ref-type="scheme" rid="molecules-10-00312-f002">Scheme 1</xref>).</p>
    <p>The position of a double bond and the stereochemistry of pyrinodemin A were examined as follows. Compounds (&#xB1;)-<bold>1</bold> [<xref ref-type="bibr" rid="B2-molecules-10-00312">2</xref>], (&#xB1;)-<bold>2</bold> [<xref ref-type="bibr" rid="B2-molecules-10-00312">2</xref>], and (+)-<bold>3</bold> were subjected to C<sub>18</sub> HPLC [Wako sil-II 5C18 RS, Wako Ind., Ltd., 4.6 x 250 mm; flow rate 1.0 mL/min: eluent; MeOH/H<sub>2</sub>O (91:9); UV detection at 263 nm] and found to be separated (<bold>1</bold>, t<sub><italic>R</italic></sub> 21.6 mim; <bold>2</bold>, t<sub><italic>R</italic></sub> 17.0 min; <bold>3</bold>, t<sub><italic>R</italic></sub> 15.8 min), while the retention time (t<sub><italic>R</italic></sub> 17.0 min) of pyrinodemin A was identical with that of <bold>2</bold> under the same condition, indicating that the position of a double bond of pyrinodemin A corresponded to that (&#x394;<sup>15&#x2019;,16&#x2019;</sup>) of <bold>2</bold>. To elucidate the stereochemistry of pyrinodemin A, compound (&#xB1;)-<bold>2</bold> was subjected to chiral HPLC [CHIRALCELL OD-H, Daicel Co., Ltd., 4.6 x 250 mm; flow rate 1.0 mL/min: eluent: hexanes/<italic>i</italic>-PrOH (95:5); UV detection at 263 nm] and found to be separated (t<sub><italic>R</italic></sub> 44 and 47 min), while the retention time of (+)-<bold>2</bold> was 47 min (<xref ref-type="fig" rid="molecules-10-00312-f001">Figure 1</xref>). On the other hand, pyrinodemin A gave the two peaks corresponding to those of (&#xB1;)-<bold>2</bold> in a ratio of 1:1 under the same conditions, indicating that pyrinodemin A is a 1:1 racemic mixture of <bold>2</bold>. Furthermore, pyrinodemin A was treated with OsO<sub>4</sub> and then NaIO<sub>4</sub> to give degradation products, one of which showed an ESIMS fragment ion peak at <italic>m/z</italic> 242 (M+Na)+, corresponding to an aldehyde (<bold>13</bold>) of C-7&#x2019;~C-15&#x2019; segment connected to a pyridine ring (<xref ref-type="scheme" rid="molecules-10-00312-f003">Scheme 2</xref>). From the results described above, it was indicated that the olefin position of pyrinodemin A was C-15&#x2019; and C-16&#x2019; (<bold>2</bold>), as proposed by Snider&#x2019;s group [<xref ref-type="bibr" rid="B2-molecules-10-00312">2</xref>], and that pyrinodemin A was a 1:1 racemic mixture of <bold>2</bold>.</p>
    <fig id="molecules-10-00312-f001" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Chiral HPLC profiles of (a) synthetic compounds (&#xB1;)-<bold>2</bold>, (b) (+)-<bold>2</bold>, and (c) pyrinodemin A</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-10-00312-g001.tif"/>
    </fig>
    <fig id="molecules-10-00312-f003" position="float">
      <object-id pub-id-type="pii">molecules-10-00312-scheme2_Scheme 2</object-id>
      <label>Scheme 2</label>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-10-00312-g003.tif"/>
    </fig>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>We thank Professor B. B. Snider (Brandeis University) for generous offer of synthetic samples of (&#xB1;)-<bold>1</bold> and (&#xB1;)-<bold>2</bold>. This work was supported in part by grants from the Akiyama Foundation and the Takeda Science Foundation and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.</p>
    </ack>
    <sec sec-type="methods">
      <title>Experimental</title>
      <sec>
        <title>General</title>
        <p>Optical rotations were determined on a JASCO P-1030 polarimeter. Infrared spectra were obtained on a JASCO FT/IR-230 spectrometer. Proton and carbon NMR spectra were recorded on a Bruker 600 MHz spectrometer. Chemical shifts are reported in &#x3B4; values relative to chloroform (&#x3B4; 7.26 for proton and &#x3B4; 77.0 for carbon NMR. EI mass spectra were measured on a JEOL JMS-DX303 spectrometer.</p>
        <p><italic>Synthetic Compound</italic> <bold>(+)-2</bold>: [&#x3B1;]<sup>25</sup><sub>D</sub> +5.5&#xB0;(<italic>c</italic> 0.6, CHCl<sub>3</sub>); IR (neat) 1575 cm<sup>-1</sup>; <sup>1</sup>H-NMR (600 MHz, CDCl<sub>3</sub>) &#x3B4; 1.25~1.50 (26H, m), 1.50~1.74 (9H, m), 1.75 (1H, m), 2.01 (4H, m), 2.60 (5H, m), 2.91 (2H, m), 3.50 (1H, m), 4.15 (1H, m), 5.33 (2H, m), 7.22 (2H, m), 7.51 (2H, m), 8.44 (4H, m); <sup>13</sup>C-NMR (150 MHz, CDCl<sub>3</sub>) &#x3B4; 26.3, 26.4, 27.0, 27.1, 27.2, 27.5, 27.8, 29.1, 29.3, 29.4, 29.7, 31.1, 33.0, 34.2, 49.9, 57.1, 72.6, 77.7, 123.2, 129.6, 130.0, 135.7, 137.9, 147.1, 149.9; HREIMS <italic>m/z</italic> 573.4643 [M<sup>+</sup>; calcd for C<sub>38</sub>H<sub>59</sub>N<sub>3</sub>O<sub>1</sub> 573.4658].</p>
        <p><italic>Synthetic Compound</italic> <bold>(+)-3</bold>: [&#x3B1;]<sup>25</sup><sub>D</sub> +6.2&#xB0;(<italic>c</italic> 0.8, CHCl<sub>3</sub>); IR (neat) 1575 cm<sup>-1</sup>; <sup>1</sup>H-NMR (600 MHz, CDCl3) &#x3B4; 1.25~1.50 (26H, m), 1.50~1.74 (9H, m), 1.77 (1H, m), 2.00 (4H, m), 2.58 (5H, m), 2.82 (2H, m), 3.45 (1H, m), 4.04 (1H, m), 5.33 (2H, m), 7.18 (2H, m), 7.47 (2H, m), 8.43 (4H, m); <sup>13</sup>C-NMR (150 MHz, CDCl<sub>3</sub>) &#x3B4; 26.3, 26.4, 27.1, 28.0, 28.8, 29.1, 31.1, 33.0, 34.3, 49.9, 57.3, 77.7, 123.2, 129.8, 135.7, 137.9, 147.1, 149.9; HREIMS <italic>m/z</italic> 573.4661 [M+; calcd for C<sub>38</sub>H<sub>59</sub>N<sub>3</sub>O<sub>1</sub> 573.4658].</p>
      </sec>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="B1-molecules-10-00312">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsuda</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hirano</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kubota</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <source>Tetrahedron Lett.</source>
          <year>1999</year>
          <volume>40</volume>
          <fpage>4819</fpage>
          <lpage>4820</lpage>
        </citation>
      </ref>
      <ref id="B2-molecules-10-00312">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Snider</surname>
              <given-names>B.B.</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <source>Tetrahedron Lett.</source>
          <year>2001</year>
          <volume>42</volume>
          <fpage>1639</fpage>
          <lpage>1642</lpage>
        </citation>
      </ref>
      <ref id="B3-molecules-10-00312">
        <label>3.</label>
        <citation citation-type="journal">
		  <label>(a)</label>
          <person-group person-group-type="author">
            <name>
              <surname>Baldwin</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Romeril</surname>
              <given-names>S.P.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Claridge</surname>
              <given-names>T.D.W.</given-names>
            </name>
          </person-group>
          <source>Org. Lett.</source>
          <year>2001</year>
          <volume>3</volume>
          <fpage>1145</fpage>
          <lpage>1148</lpage>
		</citation>
		<citation citation-type="journal">
		  <label>(b)</label>
          <person-group person-group-type="author">
            <name>
              <surname>Romeril</surname>
              <given-names>S.P.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Claridge</surname>
              <given-names>T.D.W.</given-names>
            </name>
            <name>
              <surname>Baldwin</surname>
              <given-names>J.E.</given-names>
            </name>
          </person-group>
          <source>Tetrahedron Lett.</source>
          <year>2002</year>
          <volume>43</volume>
          <fpage>327</fpage>
          <lpage>329</lpage>
		</citation>
      </ref>
      <ref id="B4-molecules-10-00312">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morimoto</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kitao</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Okita</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Shoji</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <source>Org. Lett.</source>
          <year>2003</year>
          <volume>5</volume>
          <fpage>2611</fpage>
          <lpage>2614</lpage>
        </citation>
      </ref>
      <ref id="B5-molecules-10-00312">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yoshimoto</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kawabata</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Nakamichi</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Hayashi</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <source>Chem. Lett.</source>
          <year>2001</year>
          <fpage>934</fpage>
          <lpage>945</lpage>
        </citation>
      </ref>
      <ref id="B6-molecules-10-00312">
        <label>6.</label>
        <citation citation-type="journal">
		  <label>(a)</label>
          <person-group person-group-type="author">
            <name>
              <surname>Frigerio</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Santagostino</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <source>Tetrahedron Lett.</source>
          <year>1994</year>
          <volume>35</volume>
          <fpage>8019</fpage>
          <lpage>8022</lpage>
		</citation>
		<citation citation-type="journal">
		  <label>(b)</label>
          <person-group person-group-type="author">
            <name>
              <surname>Frigerio</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Santagostino</surname>
              <given-names>M.</given-names>
            </name>
			<name>
              <surname>Sputore</surname>
              <given-names>S.</given-names>
            </name>
			<name>
              <surname>Palmisano</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <source>J. Org. Chem.</source>
          <year>1995</year>
          <volume>60</volume>
          <fpage>7272</fpage>
          <lpage>7276</lpage>
		</citation>
      </ref>
      <ref id="B7-molecules-10-00312">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oppolzer</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Siles</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Snowden</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Bakker</surname>
              <given-names>B.H.</given-names>
            </name>
            <name>
              <surname>Petrzilka</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <source>Tetrahedron</source>
          <year>1985</year>
          <volume>41</volume>
          <fpage>3497</fpage>
          <lpage>3509</lpage>
        </citation>
      </ref>
      <ref id="B8-molecules-10-00312">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>LeBel</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Balasubramanian</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <source>J. Am. Chem. Soc.</source>
          <year>1989</year>
          <volume>111</volume>
          <fpage>3363</fpage>
          <lpage>3368</lpage>
        </citation>
      </ref>
      <ref id="B9-molecules-10-00312">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Annunziata</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Cinquini</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cozzi</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Gennari</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Raimondia</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <source>J. Org. Chem.</source>
          <year>1987</year>
          <volume>52</volume>
          <fpage>4674</fpage>
          <lpage>4681</lpage>
        </citation>
      </ref>
      <ref id="B10-molecules-10-00312">
        <label>10.</label>
        <citation citation-type="journal">
		  <label>(a)</label>
          <person-group person-group-type="author">
            <name>
              <surname>Browne</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Driver</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Russell</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Sammes</surname>
              <given-names>P.G.</given-names>
            </name>
          </person-group>
          <source>J. Chem. Soc., Perkin Trans. 1</source>
          <year>2000</year>
          <fpage>653</fpage>
          <lpage>657</lpage>
		</citation>
		<citation citation-type="journal">
		  <label>(b)</label>
          <person-group person-group-type="author">
            <name>
              <surname>Lei</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Atkinson</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <source>J. Org. Chem.</source>
          <year>2000</year>
		  <volume>65</volume>
          <fpage>2560</fpage>
          <lpage>2567</lpage>
		</citation>
      </ref>
      <ref id="B11-molecules-10-00312">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davies-Coleman</surname>
              <given-names>M.T.</given-names>
            </name>
            <name>
              <surname>Faulkner</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Dubouwchik</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>G.P.</given-names>
            </name>
            <name>
              <surname>Polson</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Fairchild</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <source>J. Org. Chem.</source>
          <year>1993</year>
          <volume>58</volume>
          <fpage>5925</fpage>
          <lpage>5930</lpage>
        </citation>
      </ref>
    </ref-list>
	<fn-group>
      <fn>
      <p><italic>Sample Availability:</italic> Available from the authors.</p>
      </fn>
    </fn-group>
  </back>
</article>